List of Piramal Enterprises patents

Patents where

Current Assignee

Name

Piramal Enterprises

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8702977 Water distribution system	Patent 8702977 was granted and assigned to Piramal Enterprises on April, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8702977	April 22, 2014
‌ US Patent 9062046 Substituted imidazoquinoline derivatives as kinase inhibitors	Patent 9062046 was granted and assigned to Piramal Enterprises on June, 2015 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	9062046	June 23, 2015
‌ US Patent 11234963 Pharmaceutical combination for the treatment of cancer	Patent 11234963 was granted and assigned to Piramal Enterprises on February, 2022 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	11234963	February 1, 2022
‌ US Patent 10555931 Pharmaceutical combination for the treatment of cancer	Patent 10555931 was granted and assigned to Piramal Enterprises on February, 2020 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10555931	February 11, 2020
‌ US Patent 8357723 Prodrugs containing novel bio-cleavable linkers	Patent 8357723 was granted and assigned to Piramal Enterprises on January, 2013 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8357723	January 22, 2013
‌ US Patent 10098869 Compounds for the treatment of cancers associated with human papillomavirus	Patent 10098869 was granted and assigned to Piramal Enterprises on October, 2018 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10098869	October 16, 2018
‌ US Patent 11160789 Compounds for the treatment of cancers associated with human papillomavirus	Patent 11160789 was granted and assigned to Piramal Enterprises on November, 2021 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	11160789	November 2, 2021
‌ US Patent 8637670 Imidazo [4,5-C]quinoline derivatives and their use in the treatment of tumors and/or inflammation	Patent 8637670 was granted and assigned to Piramal Enterprises on January, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8637670	January 28, 2014
‌ US Patent 9475842 Hexadepsipeptide analogues as anticancer compounds	Patent 9475842 was granted and assigned to Piramal Enterprises on October, 2016 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	9475842	October 25, 2016
‌ US Patent 8741932 Imidazopyridine derivatives	Patent 8741932 was granted and assigned to Piramal Enterprises on June, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8741932	June 3, 2014
‌ US Patent 10144703 Process for the preparation of Verapamil hydrochloride	Patent 10144703 was granted and assigned to Piramal Enterprises on December, 2018 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10144703	December 4, 2018
‌ US Patent 10150745 Process for the preparation of clobazam and its intermediate	Patent 10150745 was granted and assigned to Piramal Enterprises on December, 2018 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	10150745	December 11, 2018
‌ US Patent 11260055 Oral pharmaceutical composition of lurasidone and preparation thereof	Patent 11260055 was granted and assigned to Piramal Enterprises on March, 2022 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	11260055	March 1, 2022
‌ US Patent 8629277 Styrenyl 1,2,4-oxadiazole compounds	Patent 8629277 was granted and assigned to Piramal Enterprises on January, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8629277	January 14, 2014
‌ US Patent 11007174 Pharmaceutical combination for the treatment of melanoma	Patent 11007174 was granted and assigned to Piramal Enterprises on May, 2021 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	11007174	May 18, 2021
‌ US Patent 8895605 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer	Patent 8895605 was granted and assigned to Piramal Enterprises on November, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8895605	November 25, 2014
‌ US Patent 11198703 Process for the preparation of SGLT2 inhibitors and intermediates thereof	Patent 11198703 was granted and assigned to Piramal Enterprises on December, 2021 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	11198703	December 14, 2021
‌ US Patent 8805594 Control system for a water distribution system	Patent 8805594 was granted and assigned to Piramal Enterprises on August, 2014 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	8805594	August 12, 2014
‌ US Patent 10273230 Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof	Patent 10273230 was granted and assigned to Piramal Enterprises on April, 2019 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10273230	April 30, 2019
‌ US Patent 10428097 Process for preparation of fosaprepitant dimeglumine and an intermediate thereof	Patent 10428097 was granted and assigned to Piramal Enterprises on October, 2019 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10428097	October 1, 2019
‌ US Patent 10980776 Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck	Patent 10980776 was granted and assigned to Piramal Enterprises on April, 2021 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10980776	April 20, 2021
‌ US Patent 9034400 Process for preparation of a herbal extract	Patent 9034400 was granted and assigned to Piramal Enterprises on May, 2015 by the United States Patent and Trademark Office.		Piramal Enterprises	United States Patent and Trademark Office	9034400	May 19, 2015
‌ US Patent 10105373 Fused triterpene compounds and uses thereof	Patent 10105373 was granted and assigned to Piramal Enterprises on October, 2018 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10105373	October 23, 2018
‌ US Patent 10428033 Process for the preparation of vortioxetine and salts thereof	Patent 10428033 was granted and assigned to Piramal Enterprises on October, 2019 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10428033	October 1, 2019
‌ US Patent 10245251 Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck	Patent 10245251 was granted and assigned to Piramal Enterprises on April, 2019 by the United States Patent and Trademark Office.	Piramal Enterprises	Piramal Enterprises	United States Patent and Trademark Office	10245251	April 2, 2019

Results per page:

48 results

0 selected

48 results

0 selected